# Tafenoquine and Primaquine in Colostrum and Breast Milk

> **NCT04984759** · PHASE4 · WITHDRAWN · sponsor: **University of Oxford**

## Conditions studied

- Healthy Lactating Women

## Interventions

- **DRUG:** Primaquine
- **DRUG:** Tafenoquine

## Key facts

- **NCT ID:** NCT04984759
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-07-01
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-06-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Local EC requested that the arms of study be submitted as separate protocols so they could respond to the different risk of each arm. In response investigators have withdrawn this protocol and begun separate submissions, starting with NCT06191458.
- **Last updated:** 2024-04-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04984759

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04984759, "Tafenoquine and Primaquine in Colostrum and Breast Milk". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT04984759. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*